戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 if parathyroid hormone is not followed by an antiresorptive agent.
2 y, whose appearance could be prevented by an antiresorptive agent.
3 in the presence of zoledronic acid, a potent antiresorptive agent.
4 pounds for the development of a new class of antiresorptive agents.
5  impact of a locally or systemically applied antiresorptive agent (alendronate) on simvastatin-induce
6  use parathyroid hormone in combination with antiresorptive agents and sequentially are reviewed.
7                                        Novel antiresorptive agents are being developed.
8                                          The antiresorptive agents are clearly able to preserve bone
9                                              Antiresorptive agents are widely used to treat osteoporo
10                                              Antiresorptive agents, especially bisphosphonates, appea
11 se findings suggest that, among women taking antiresorptive agents, greater increases in BMD are asso
12                      Therapy with individual antiresorptive agents has been shown to be effective for
13    To reduce bone loss and improve strength, antiresorptive agents have been instituted.
14 e effects of these pharmacologically diverse antiresorptive agents on gene expression in bone has not
15 ologists were less likely to be treated with antiresorptive agents (OR 0.49 [95% CI 0.28-0.86]).
16 thyroid hormone in the future, the choice of antiresorptive agent should be carefully considered.
17                                              Antiresorptive agents such as bisphosphonates are used w
18 ciated bone disease are available, including antiresorptive agents such as denosumab and bisphosphona
19 rapy approaches with parathyroid hormone and antiresorptive agents to optimize efficacy outcomes.
20 reatment (parathyroid hormone followed by an antiresorptive agent), which aims to maintain or build o
21                      Alendronate (ALN) is an antiresorptive agent widely used for the treatment of os
22 e that combining parathyroid hormone with an antiresorptive agent will enhance its effect on bone min
23  is also possible that the combination of an antiresorptive agent with an anabolic agent could be mor
24 fonamides like 55 form a new class of potent antiresorptive agents with possible therapeutic use in d

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。